Skip to main content

CAP TODAY/Seagen Webinar: HER2 Testing in Metastatic Colorectal Cancer (mCRC)

Thank you

This live web event has ended. Thank you for attending.

Description


HER2 Testing in Metastatic
Colorectal Cancer (mCRC)

Why should you register now for this webinar?

  • HER2 testing in mCRC opens a powerful new window for patients
  • Presenters: Jaclyn Hechtman, MD, and John Marshall, MD
  • Moderated by: Bob McGonnagle, Publisher, CAP TODAY
What will this webinar empower you to do?
  • Learn about testing methodology to identify HER2+ mCRC and
    introduce a new treatment for patients with HER2+ mCRC
  • Discuss the importance of testing for HER2 in mCRC
  • Look at efficacy and safety data from the MOUNTAINEER trial
CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Seagen.

Contributors

  • Jaclyn Hechtman, MD

    Oncologic and Molecular Pathologist
    Caris Life Sciences

  • John Marshall, MD

    Professor of Medicine and Oncology
    Director, The Ruesch Center for the Cure of GI Cancers
    Washington, DC

  • Bob McGonnagle

    Publisher, CAP TODAY

August 9, 2023
Wed 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136